Collegeville, PA, United States of America

Linda S Barton


 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Linda S. Barton: Innovator in TRPV4 Antagonists**

Introduction

Linda S. Barton, an inventive force based in Collegeville, PA, is recognized for her significant contributions to the field of pharmaceutical innovations. With two patents to her name, she has demonstrated a commitment to advancing medical science through her groundbreaking work.

Latest Patents

Among her latest patents is a remarkable development concerning TRPV4 antagonists. This invention focuses on pyrrolidine sulfonamide analogs and explores pharmaceutical compositions that incorporate them. Her research showcases the potential uses of these compounds as TRPV4 antagonists, which could lead to significant advancements in therapeutic applications.

Career Highlights

Linda has made substantial strides in her career, particularly through her engagements at major pharmaceutical companies. She has worked at GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Intellectual Property (No. 2) Limited, where her innovative spirit was nurtured and her skills honed.

Collaborations

Throughout her career, Linda has collaborated with esteemed colleagues, including Edward J. Brnardic and Carl A. Brooks. These partnerships have further enriched her research experience and contributed to the success of her inventions.

Conclusion

Linda S. Barton's achievements in the realm of TRPV4 antagonists underscore her dedication to innovation in the pharmaceutical industry. Her contributions not only reflect her talent but also the potential impact of her inventions on medical science and patient care. As she continues her work, the future looks promising for further breakthroughs under her guidance.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…